Endomorphin-2 with a beta turn backbone constraint retains the potent mu-opioid receptor agonist properties: IF 4.898

Csaba Tömböly, Steven Ballet, Debby Feytens, Katalin E. Köver, Borics Attila, Sandor Lovas, Mahmoud Al-Khrasani, Furst Zsuzsanna, Géza Tóth, Sandor Benyhe, Dirk Tourwe

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Abstract

The constitutional similarity with different secondary structure preference between the Aba-Gly and the spiro-Aba-Gly scaffolds were exploited to design the novel endomorphin-2 analogs Tyr-spiro-(R/S)-Aba-Gly-Phe-NH2 and Tyr-(R/S)-Aba-Gly-Phe-NH2. The (R)-spiro analog was found to be a potent and selective ?-opioid agonist/partial agonist (Kiµ = 29.3 nM, IC50 = 50 nM, Ke = 0.57). NMR expts. and mol. modeling indicated that its backbone adopts mainly a ?-turn in aq. soln.
Original languageEnglish
Pages (from-to)173-177
Number of pages5
JournalJournal of Medicinal Chemistry
Volume51
Issue number1
Publication statusPublished - 2008

Keywords

  • peptides

Fingerprint

Dive into the research topics of 'Endomorphin-2 with a beta turn backbone constraint retains the potent mu-opioid receptor agonist properties: IF 4.898'. Together they form a unique fingerprint.

Cite this